2026年全球家庭性行為感染感染檢測市場報告

近年來，居家性行為感染（STI）檢測市場發展迅速。預計該市場規模將從2025年的19.3億美元成長至2026年的21.7億美元，複合年成長率（CAGR）為12.8%。過去幾年成長要素包括：全球性行為感染盛行率上升、人們對性傳染感染早期診斷和治療的認知不斷提高、線上和遠距遠端醫療服務的日益普及、愛滋病毒和性傳染感染篩檢公共衛生措施的加強，以及消費者對私密居家醫療解決方案的偏好日益增強。

預計未來幾年，居家性行為感染(STI) 檢測市場將快速成長，到 2030 年將達到 35.5 億美元，複合年成長率 (CAGR) 為 13.0%。預測期內的成長主要受以下因素驅動：人工智慧驅動的數位性健康平台的日益普及、對多參數快速居家 STI 診斷試劑盒的需求不斷成長、互聯互通和基於應用程式的檢測生態系統的整合、D2C（直接面對消費者）醫療保健分銷管道的興趣，以及人們對預防性篩檢性日益成長的興趣。預測期內的關鍵趨勢包括：用於居家私密檢測的隱藏式自取樣性行為感染篩檢盒的普及率不斷提高、對能夠提供快速結果的性行為感染診斷解決方案的需求不斷成長、年輕一代越來越傾向於選擇郵購檢測服務、多感染疾病居家 STI 檢測組合的普及率不斷提高，以及透過線上藥局和 D2C（直接分銷商）。

性健康意識的提高預計將推動居家性行為感染（STI）檢測市場的成長。性健康意識是指個人了解性傳染感染、其傳播途徑、預防方法、定期檢測對於早期發現和治療的重要性。推動這項意識提高的關鍵因素包括公共衛生宣傳活動以及減少對性傳染感染檢測的污名化，促使更多人主動尋求相關資訊和檢測途徑。這種意識的提高鼓勵人們在傳統醫療機構之外選擇私密、便捷且易於獲取的檢測方案，從而支持了對居家性傳播感染檢測日益成長的需求。例如，根據英國英國安全局的數據，截至2025年12月，傳染性梅毒的診斷數量預計將增加1.7%，從2023年的9,375例增加到2024年的9,535例。因此，性健康意識的提高正在促進和推動居家性行為感染（STI）檢測市場的成長。

領先的家用性傳染感染檢測公司正致力於開發先進的診斷技術，例如無需儀器的聚合酵素鏈鎖反應(PCR) 平台，以提高檢測準確性、縮短檢測結果計算時間，並使用戶能夠在家中獲得檢查室級別的檢測結果。無需儀器的聚合酵素鏈鎖反應(PCR) 平台是一種一體化的分子診斷設備，使用者無需使用傳統檢測設備即可在家採集檢體並獲得高度準確的病原體檢測結果。該平台還整合了數位系統，可安全交付檢測結果並提供遠端醫療支援。例如，2025 年 11 月，總部位於美國的醫療診斷公司 Visby Medical 推出了一款獲得 FDA 批准的家用性行為感染PCR檢測套組。此檢測套組可檢測披衣菌感染、淋病和滴蟲病，並在約 30 分鐘內提供檢測結果。它是一款無需儀器的一次性設備，並與數位平台配合使用，可提供安全的結果報告和遠端醫療後續服務。該產品旨在支援直接向消費者交付，提高分子診斷的準確性，增強檢測的便利性，並利用遠端醫療實現無縫治療指導。

目錄

第1章：執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球居家性行為感染感染檢測市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 數位化、雲端運算、巨量資料、網路安全
  • 人工智慧和自主智慧
  • 物聯網、智慧基礎設施、互聯生態系統
  • 身臨其境型技術（AR/VR/XR）與數位體驗
• 主要趨勢
  • 擴大使用隱藏的、可自行採集樣本的性性行為感染(STI)篩檢盒進行私密居家檢測。
  • 對能夠快速提供結果的性行為感染感染診斷解決方案的需求日益成長
  • 年輕人對郵購性健康檢測服務的需求日益成長。
  • 提高家用性健康檢測套組的普及率，以檢測多種感染疾病。
  • 擴大性健康檢測的線上藥局和直接面對消費者的通路。

第5章 終端用戶產業市場分析

• 個人消費者
• 醫療服務提供方
• 公共衛生計劃
• 診斷檢查室
• 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球居家性行為感染感染檢測市場：PESTEL 分析
• 全球居家性行為感染傳染感染檢測市場：規模、對比及成長率分析
• 全球居家性行為感染感染檢測市場表現：規模與成長，2020-2025年
• 全球居家性行為感染感染檢測市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按類型
• 快速側向流動免疫檢測、基於分子或核酸擴增技術（NAAT）的試劑盒、多重檢測板測試及其他類型。
• 感染疾病
• 人類免疫力缺乏病毒（HIV）、披衣菌感染披衣菌（CT）、淋病奈瑟菌（NG）、梅毒、滴蟲病、人類乳突病毒（HPV）、B型肝炎和C型肝炎以及其他感染疾病。
• 樣本
• 血液檢體、尿液檢體、拭子檢體
• 透過散佈
• 線上藥局和 D2C 平台、零售藥局、公共衛生分發計劃和其他通路。
• 最終用戶
• 一般消費者、醫療保健提供者、公共衛生項目
• 按類型細分：快速側向流動免疫檢測
• 人類免疫力缺乏病毒（HIV）抗體檢測、梅毒抗體檢測、披衣菌感染抗原檢測、淋病抗原檢測、B型肝炎表面抗原檢測
• 按類型細分：基於分子或核酸擴增技術（NAAT）的試劑盒
• 人類免疫力缺乏病毒（HIV）核酸、披衣菌感染披衣菌核酸、淋病奈瑟菌核酸、陰道滴蟲核酸、黴漿菌支原體核酸檢測
• 按類型細分：多工面板測試
• 人類免疫力缺乏病毒 (HIV) 和梅毒聯合檢測、披衣菌感染和淋病聯合檢測、細菌性行為感染綜合檢測、病毒性行為感染感染綜合檢測、多重病原體健康篩檢
• 按類型細分：其他類型
• 自採集檢體盒、郵寄檢測套組、數位或連網家用檢測套組、微流體晶片實驗室檢測套組

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 家庭性行為感染性傳染感染檢測市場：競爭格局與市場佔有率（2024 年）
• 家庭性行為感染傳染感染檢測市場：公司評估矩陣
• 居家性行為感染感染檢測市場：公司簡介
  • Becton Dickinson and Company（BD）
  • Laboratory Corporation of America Holdings
  • Randox Laboratories Ltd
  • LetsGetChecked
  • Everly Health Inc

第37章 其他大型企業和創新企業

• myLAB Box LLC, Preventx Ltd, MySTDTestKits, RapidTest.co.uk Ltd, Got Lucky Labs Inc, Biopanda Reagents Ltd, Rapid Labs Ltd, Walk-In Lab LLC, Any Lab Test Now Inc, 4U Health Ltd, Quest Diagnostics Incorporated, ACON Biotech（Hangzhou）Co. Ltd, UroSure Inc, Yoxly Ltd, Genedia Co. Ltd

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年居家性行為感染傳染感染檢測市場：提供新機會的國家
• 2030年居家性行為感染傳染感染檢測市場：新興細分領域機會展望
• 2030年家庭性行為感染感染檢測市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

At-home sexually transmitted infection (STI) testing refers to diagnostic kits that enable individuals to collect their own samples in a private environment, which are then either sent to accredited laboratories or processed using rapid test methods at home. The primary objective is to improve accessibility, confidentiality, and convenience in STI screening, enabling early diagnosis and timely treatment while reducing stigma and barriers associated with traditional clinic-based testing.

The primary types of at-home sexually transmitted infection (STI) testing include rapid lateral flow immunoassays, molecular or nucleic acid amplification technology (NAAT)-based kits, multiplex panel testing, and other types. Rapid lateral flow immunoassays refer to simple, quick testing methods that detect the presence of specific STI markers in a sample for preliminary diagnosis at home. These solutions are based on infections such as human immunodeficiency virus (HIV), Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), syphilis, trichomoniasis, human papillomavirus (HPV), hepatitis B and C, and other infections, and they utilize sample types including blood samples, urine samples, and swab samples. The various distribution channels involved are online pharmacies and D2C platforms, retail pharmacies, public health distribution programs, and other distribution channels, and they are used by several end users such as individual consumers, healthcare providers, and public health programs.

Tariffs are impacting the at-home sexually transmitted infection (STI) testing market by increasing the cost of imported diagnostic reagents, biosensors, microfluidic chips, and semiconductor-enabled testing devices used in self-testing kits and laboratory analysis systems. This is slowing down the production and distribution of advanced molecular or nucleic acid amplification technology (NAAT)-based kits and multiplex panel testing solutions, particularly in regions dependent on imported healthcare technologies such as Asia-Pacific and Latin America. Hardware-intensive segments such as digital or connected at-home testing kits and microfluidic lab-on-chip testing kits are most affected due to global supply chain dependencies. However, tariffs are also driving local manufacturing expansion, regional supplier diversification, and increased investment in domestic diagnostic production ecosystems, creating long-term resilience in the market.

The at-home sexually transmitted infection (STI) testing market research report is one of a series of new reports from The Business Research Company that provides at-home sexually transmitted infection (STI) testing market statistics, including at-home sexually transmitted infection (STI) testing industry global market size, regional shares, competitors with a at-home sexually transmitted infection (STI) testing market share, detailed at-home sexually transmitted infection (STI) testing market segments, market trends and opportunities, and any further data you may need to thrive in the at-home sexually transmitted infection (STI) testing industry. This at-home sexually transmitted infection (STI) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The at-home sexually transmitted infection (STI) testing market size has grown rapidly in recent years. It will grow from $1.93 billion in 2025 to $2.17 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to rising prevalence of sexually transmitted infections globally, increasing awareness regarding early STI diagnosis and treatment, growing penetration of online healthcare and telemedicine services, expanding public health initiatives for HIV and STI screening, increasing consumer preference for confidential home healthcare solutions.

The at-home sexually transmitted infection (STI) testing market size is expected to see rapid growth in the next few years. It will grow to $3.55 billion by 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to growing adoption of AI-enabled digital sexual health platforms, rising demand for multiplex and rapid at-home STI diagnostic kits, increasing integration of connected and app-based testing ecosystems, expanding availability of D2C healthcare distribution channels, growing focus on preventive sexual wellness and routine screening practices. Major trends in the forecast period include increasing adoption of discreet self-collection STI screening kits for private home-based testing, growing demand for rapid turnaround sexually transmitted infection diagnostic solutions, rising preference for mail-in laboratory sexual health testing services among young adults, increasing availability of multi infection at-home sexual wellness testing panels, growing expansion of online pharmacy and direct-to-consumer sexual health testing distribution channels.

The growing awareness of sexual health is expected to propel the growth of the at-home sexually transmitted infection (STI) testing market going forward. Sexual health awareness refers to individuals' understanding of STIs, their transmission pathways, prevention methods, and the importance of regular testing for early detection and treatment. The increasing focus on sexual health awareness is largely driven by public health campaigns and the progressive destigmatization of STI testing, which is encouraging more individuals to proactively seek information and testing options. The rising awareness of sexual health is supporting increased demand for at-home STI testing by motivating individuals to adopt confidential, convenient, and accessible testing solutions outside traditional clinical environments. For instance, in December 2025, according to the UK Health Security Agency, a UK-based government agency, infectious syphilis diagnoses rose by 1.7%, increasing from 9,375 cases in 2023 to 9,535 cases in 2024. Therefore, growing awareness of sexual health is contributing to and propelling the growth of the at-home sexually transmitted infection (STI) testing market.

Leading companies operating in the at-home STI testing market are focusing on developing advanced diagnostic technologies, such as instrument-free polymerase chain reaction platforms, to enhance detection accuracy, reduce turnaround time, and expand access to laboratory-grade results from home. Instrument-free polymerase chain reaction platforms refer to self-contained molecular diagnostic devices that enable users to collect samples at home and obtain highly accurate pathogen detection results without requiring traditional laboratory equipment, while integrating digital systems for secure result delivery and telehealth support. For example, in November 2025, Visby Medical, a US-based medical diagnostics company, launched its FDA-authorized at-home PCR test for sexually transmitted infections, which detects chlamydia, gonorrhea, and trichomoniasis, delivers results in approximately 30 minutes, operates as an instrument-free single-use device, and integrates with digital platforms to provide secure result reporting and virtual care follow-up. It is designed to support direct-to-consumer access, enhance molecular accuracy, improve testing convenience, and enable seamless telehealth-enabled treatment guidance.

In September 2025, Tia Health, a US-based women's healthcare platform, partnered with Molecular Testing Labs to introduce the first FDA-cleared home-collected 4-plex STI test. Through this partnership, the companies seek to improve accessibility to at-home sexually transmitted infection (STI) testing by enabling users to collect samples at home and obtain accurate, laboratory-validated results. Molecular Testing Labs is a US-based diagnostic company specializing in at-home STI testing services.

Major companies operating in the at-home sexually transmitted infection (sti) testing market are Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings, Randox Laboratories Ltd, LetsGetChecked, Everly Health Inc, myLAB Box LLC, Preventx Ltd, MySTDTestKits, RapidTest. co. uk Ltd, Got Lucky Labs Inc, Biopanda Reagents Ltd, Rapid Labs Ltd, Walk-In Lab LLC, Any Lab Test Now Inc, 4U Health Ltd, Quest Diagnostics Incorporated, ACON Biotech (Hangzhou) Co. Ltd, UroSure Inc, Yoxly Ltd, Genedia Co. Ltd

North America was the largest region in the at-home sexually transmitted infection (STI) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the at-home sexually transmitted infection (STI) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the at-home sexually transmitted infection (STI) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The at-home sexually transmitted infection (STI) testing market consists of revenues earned by entities by providing services such as online consultation with healthcare professionals, digital result reporting and tracking, prescription and treatment guidance, and partner notification support. The market value includes the value of related goods sold by the service provider or included within the service offering. The at-home sexually transmitted infection (STI) testing market also includes sales of HIV self-test kits, chlamydia and gonorrhea dual test kits, syphilis rapid test kits, and HPV home screening kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

At-Home Sexually Transmitted Infection (STI) Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses at-home sexually transmitted infection (sti) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for at-home sexually transmitted infection (sti) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The at-home sexually transmitted infection (sti) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Rapid Lateral Flow Immunoassays; Molecular Or Nucleic Acid Amplification Technology (NAAT)-Based Kits; Multiplex Panel Testing; Other Types
• 2) By Infection: Human Immunodeficiency Virus (HIV); Chlamydia Trachomatis (CT); Neisseria Gonorrhoeae (NG); Syphilis; Trichomoniasis; Human Papillomavirus (HPV); Hepatitis B And C; Other Infections
• 3) By Sample: Blood Samples; Urine Samples; Swab Samples
• 4) By Distribution: Online Pharmacies And D2C Platforms; Retail Pharmacies; Public Health Distribution Programs; Other Distributions
• 5) By End User: Individual Consumers; Healthcare Providers; Public Health Programs
• Subsegments:
• 1) By Rapid Lateral Flow Immunoassays: Of Human Immunodeficiency Virus Antibody Detection; Of Syphilis Antibody Detection; Of Chlamydia Antigen Detection; Of Gonorrhea Antigen Detection; Of Hepatitis B Surface Antigen Detection
• 2) By Molecular Or Nucleic Acid Amplification Technology (NAAT) Based Kits: Of Human Immunodeficiency Virus Nucleic Acid Detection; Of Chlamydia Trachomatis Nucleic Acid Detection; Of Neisseria Gonorrhoeae Nucleic Acid Detection; Of Trichomonas Vaginalis Nucleic Acid Detection; Of Mycoplasma Genitalium Nucleic Acid Detection
• 3) By Multiplex Panel Testing: Of Combined Human Immunodeficiency Virus And Syphilis Detection; Of Combined Chlamydia And Gonorrhea Detection; Of Comprehensive Bacterial Sexually Transmitted Infection Panel; Of Comprehensive Viral Sexually Transmitted Infection Panel; Of Multi Pathogen Sexual Health Screening Panel
• 4) By Other Types: Self-Collection Sample Kits; Mail-In Laboratory Testing Kits; Digital Or Connected At-Home Testing Kits; Microfluidic Lab-On-Chip Testing Kits
• Companies Mentioned: Becton Dickinson and Company (BD); Laboratory Corporation of America Holdings; Randox Laboratories Ltd; LetsGetChecked; Everly Health Inc; myLAB Box LLC; Preventx Ltd; MySTDTestKits; RapidTest.co.uk Ltd; Got Lucky Labs Inc; Biopanda Reagents Ltd; Rapid Labs Ltd; Walk-In Lab LLC; Any Lab Test Now Inc; 4U Health Ltd; Quest Diagnostics Incorporated; ACON Biotech (Hangzhou) Co. Ltd; UroSure Inc; Yoxly Ltd; Genedia Co. Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. At-Home Sexually Transmitted Infection (STI) Testing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global At-Home Sexually Transmitted Infection (STI) Testing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. At-Home Sexually Transmitted Infection (STI) Testing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global At-Home Sexually Transmitted Infection (STI) Testing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Immersive Technologies (AR/VR/XR) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Discreet Self-Collection STI Screening Kits For Private Home-Based Testing
  • 4.2.2 Growing Demand For Rapid Turnaround Sexually Transmitted Infection Diagnostic Solutions
  • 4.2.3 Rising Preference For Mail-In Laboratory Sexual Health Testing Services Among Young Adults
  • 4.2.4 Increasing Availability Of Multi Infection At-Home Sexual Wellness Testing Panels
  • 4.2.5 Growing Expansion Of Online Pharmacy And Direct-To-Consumer Sexual Health Testing Distribution Channels

5. At-Home Sexually Transmitted Infection (STI) Testing Market Analysis Of End Use Industries

• 5.1 Individual Consumers
• 5.2 Healthcare Providers
• 5.3 Public Health Programs
• 5.4 Diagnostic Laboratories
• 5.5 Other End Users

6. At-Home Sexually Transmitted Infection (STI) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global At-Home Sexually Transmitted Infection (STI) Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global At-Home Sexually Transmitted Infection (STI) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global At-Home Sexually Transmitted Infection (STI) Testing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global At-Home Sexually Transmitted Infection (STI) Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global At-Home Sexually Transmitted Infection (STI) Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global At-Home Sexually Transmitted Infection (STI) Testing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. At-Home Sexually Transmitted Infection (STI) Testing Market Segmentation

• 9.1. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rapid Lateral Flow Immunoassays, Molecular Or Nucleic Acid Amplification Technology (NAAT)-Based Kits, Multiplex Panel Testing, Other Types
• 9.2. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG), Syphilis, Trichomoniasis, Human Papillomavirus (HPV), Hepatitis B And C, Other Infections
• 9.3. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood Samples, Urine Samples, Swab Samples
• 9.4. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Online Pharmacies And D2C Platforms, Retail Pharmacies, Public Health Distribution Programs, Other Distributions
• 9.5. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Individual Consumers, Healthcare Providers, Public Health Programs
• 9.6. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Sub-Segmentation Of Rapid Lateral Flow Immunoassays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Immunodeficiency Virus Antibody Detection, Syphilis Antibody Detection, Chlamydia Antigen Detection, Gonorrhea Antigen Detection, Hepatitis B Surface Antigen Detection
• 9.7. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Sub-Segmentation Of Molecular Or Nucleic Acid Amplification Technology (NAAT) Based Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Immunodeficiency Virus Nucleic Acid Detection, Chlamydia Trachomatis Nucleic Acid Detection, Neisseria Gonorrhoeae Nucleic Acid Detection, Trichomonas Vaginalis Nucleic Acid Detection, Mycoplasma Genitalium Nucleic Acid Detection
• 9.8. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Sub-Segmentation Of Multiplex Panel Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Combined Human Immunodeficiency Virus And Syphilis Detection, Combined Chlamydia And Gonorrhea Detection, Comprehensive Bacterial Sexually Transmitted Infection Panel, Comprehensive Viral Sexually Transmitted Infection Panel, Multi Pathogen Sexual Health Screening Panel
• 9.9. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Self-Collection Sample Kits, Mail-In Laboratory Testing Kits, Digital Or Connected At-Home Testing Kits, Microfluidic Lab-On-Chip Testing Kits

10. At-Home Sexually Transmitted Infection (STI) Testing Market Regional And Country Analysis

• 10.1. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific At-Home Sexually Transmitted Infection (STI) Testing Market

• 11.1. Asia-Pacific At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China At-Home Sexually Transmitted Infection (STI) Testing Market

• 12.1. China At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India At-Home Sexually Transmitted Infection (STI) Testing Market

• 13.1. India At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan At-Home Sexually Transmitted Infection (STI) Testing Market

• 14.1. Japan At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia At-Home Sexually Transmitted Infection (STI) Testing Market

• 15.1. Australia At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia At-Home Sexually Transmitted Infection (STI) Testing Market

• 16.1. Indonesia At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea At-Home Sexually Transmitted Infection (STI) Testing Market

• 17.1. South Korea At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan At-Home Sexually Transmitted Infection (STI) Testing Market

• 18.1. Taiwan At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia At-Home Sexually Transmitted Infection (STI) Testing Market

• 19.1. South East Asia At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe At-Home Sexually Transmitted Infection (STI) Testing Market

• 20.1. Western Europe At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK At-Home Sexually Transmitted Infection (STI) Testing Market

• 21.1. UK At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany At-Home Sexually Transmitted Infection (STI) Testing Market

• 22.1. Germany At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France At-Home Sexually Transmitted Infection (STI) Testing Market

• 23.1. France At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy At-Home Sexually Transmitted Infection (STI) Testing Market

• 24.1. Italy At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain At-Home Sexually Transmitted Infection (STI) Testing Market

• 25.1. Spain At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe At-Home Sexually Transmitted Infection (STI) Testing Market

• 26.1. Eastern Europe At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia At-Home Sexually Transmitted Infection (STI) Testing Market

• 27.1. Russia At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America At-Home Sexually Transmitted Infection (STI) Testing Market

• 28.1. North America At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA At-Home Sexually Transmitted Infection (STI) Testing Market

• 29.1. USA At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada At-Home Sexually Transmitted Infection (STI) Testing Market

• 30.1. Canada At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America At-Home Sexually Transmitted Infection (STI) Testing Market

• 31.1. South America At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil At-Home Sexually Transmitted Infection (STI) Testing Market

• 32.1. Brazil At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East At-Home Sexually Transmitted Infection (STI) Testing Market

• 33.1. Middle East At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa At-Home Sexually Transmitted Infection (STI) Testing Market

• 34.1. Africa At-Home Sexually Transmitted Infection (STI) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. At-Home Sexually Transmitted Infection (STI) Testing Market Regulatory and Investment Landscape

36. At-Home Sexually Transmitted Infection (STI) Testing Market Competitive Landscape And Company Profiles

• 36.1. At-Home Sexually Transmitted Infection (STI) Testing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. At-Home Sexually Transmitted Infection (STI) Testing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. At-Home Sexually Transmitted Infection (STI) Testing Market Company Profiles
  • 36.3.1. Becton Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Randox Laboratories Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. LetsGetChecked Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Everly Health Inc Overview, Products and Services, Strategy and Financial Analysis

37. At-Home Sexually Transmitted Infection (STI) Testing Market Other Major And Innovative Companies

• myLAB Box LLC, Preventx Ltd, MySTDTestKits, RapidTest.co.uk Ltd, Got Lucky Labs Inc, Biopanda Reagents Ltd, Rapid Labs Ltd, Walk-In Lab LLC, Any Lab Test Now Inc, 4U Health Ltd, Quest Diagnostics Incorporated, ACON Biotech (Hangzhou) Co. Ltd, UroSure Inc, Yoxly Ltd, Genedia Co. Ltd

38. Global At-Home Sexually Transmitted Infection (STI) Testing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The At-Home Sexually Transmitted Infection (STI) Testing Market

41. At-Home Sexually Transmitted Infection (STI) Testing Market High Potential Countries, Segments and Strategies

• 41.1 At-Home Sexually Transmitted Infection (STI) Testing Market In 2030 - Countries Offering Most New Opportunities
• 41.2 At-Home Sexually Transmitted Infection (STI) Testing Market In 2030 - Segments Offering Most New Opportunities
• 41.3 At-Home Sexually Transmitted Infection (STI) Testing Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer